Details for Ireland Supplementary Protection Certificate: 2019/002
Ireland Supplementary Protection Certificate: 2019/002
| Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2504364 | 2019/002 | Ireland | PRODUCT NAME: DURVALUMAB; REGISTRATION NO/DATE: EU/1/18/1322 20180921 | ⤷ Start Trial |
| >Country | >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Description | >SPC Expiration |
